Browse by tag
25 articles tagged with this topic.
Serotonin reuptake selectivity versus dual serotonin-norepinephrine reuptake, anxiety and depression indications, discontinuation syndromes, bleeding with NSAIDs, and hypertension monitoring with SNRIs.
Read articleTime-dependent killing, trough versus AUC targets in modern curricula, nephrotoxicity surveillance, red man syndrome histamine release, and infusion rate counseling.
Read articleVitamin K epoxide reductase inhibition, INR targets, dietary consistency teaching, genotype considerations in curricula, and bleeding reversal education without replacing protocols.
Read articleCholesterol synthesis suppression, LDL lowering magnitude, hepatotoxicity monitoring teaching, myopathy and CK, drug interactions via CYP3A4, and diabetes risk discussions.
Read articleSerotonergic toxidrome triad of mental status change, autonomic instability, and neuromuscular hyperactivity including clonus; common precipitants; supportive care themes; differentiation from NMS.
Read articleDirect thrombin versus factor Xa inhibition, renal dosing anchors, p-gp and CYP interaction clusters, perioperative management themes, and reversal agent education at overview depth.
Read articleGlucocorticoid receptor genomic effects, hyperglycemia, hypertension, osteoporosis, mood changes, adrenal suppression with chronic use, and perioperative stress-dose teaching at overview depth.
Read articleL-type calcium channel antagonism, vascular selectivity, AV node effects, heart failure cautions, and interaction monitoring for pharmacy licensing review.
Read articleReceptor selectivity, heart failure and post-MI roles, bronchospasm risk, masking hypoglycemia, and monitoring pearls for pharmacy boards and clinical rotations.
Read articleCompare angiotensin II receptor blockers with ACE inhibitors: bradykinin-related adverse effects, pregnancy risk, monitoring, and when guideline pathways favor one class.
Read articleSABA rescue, inhaled corticosteroid controllers, LABA combination safety framing, LAMA add-on, leukotriene modifiers, and biologic eligibility themes at overview depth for boards.
Read articleBronchodilator classes, inhaler device types, exacerbation reduction claims in teaching summaries, pneumonia risk discussions with ICS in COPD, and oxygen therapy reminders.
Read articleD2 antagonism extrapyramidal symptoms, prolactin elevation, anticholinergic burden, metabolic syndrome monitoring, and QT prolongation with ziprasidone-like teaching anchors.
Read articleConcentration-dependent killing, peak and trough teaching legacy, extended interval dosing, synergy with beta-lactams, and adjustment for obesity and critical illness for exams.
Read articleCompare vitamin K antagonists, parenteral indirect thrombin inhibitors, low molecular weight heparins, and direct oral anticoagulants at a systems level for boards and clinical rotations.
Read articleAngiotensin-converting enzyme inhibitor mechanism, bradykinin-related cough and angioedema, hyperkalemia, renal monitoring, and exam-ready counseling for pharmacy and clinical pharmacology review.
Read articleBeta-lactams, glycopeptides, aminoglycosides, fluoroquinolones, macrolides, tetracyclines, oxazolidinones, and nitroimidazoles mapped to spectra and toxicities for rapid board review.
Read articleIrreversible H+/K+ ATPase inhibition, GERD and PUD indications, clopidogrel interaction teaching evolution, magnesium deficiency, C difficile risk discussions, and long-term bone considerations.
Read articleADME versus receptor occupancy, half-life and steady state, clearance routes, EC50 and Emax teaching bridges, therapeutic windows, and how organ failure shifts both PK and PD endpoints.
Read articleMu-opioid receptor agonism, equianalgesic teaching cautions, constipation prophylaxis, respiratory depression recognition, tolerance versus dependence, and multimodal analgesia framing.
Read articleCompetitive mu-opioid antagonism, intranasal versus intramuscular products, redosing strategies in education, precipitated withdrawal recognition, and community access laws at overview level.
Read articleAMPK-related hepatic glucose suppression, GI tolerability, vitamin B12 monitoring, renal eGFR thresholds, contrast precautions, and lactic acidosis rarity in modern use.
Read articleCompare furosemide-like loops with thiazide and thiazide-like agents: nephron sites, electrolyte risks, gout, heart failure versus hypertension roles, and monitoring.
Read articleRapid, short, intermediate, and long-acting insulin pharmacokinetics, U-500 considerations, pump versus basal-bolus concepts, and hypoglycemia safety teaching.
Read article